All News #Library
Biotech
Minerva Announces Leadership Transition
02 Apr 2026 //
GLOBENEWSWIRE
Minerva Neurosciences Launches Global Phase 3 Roluperidone Trial
31 Mar 2026 //
GLOBENEWSWIRE
Minerva Neurosciences Reveals Roluperidone-Olanzapine Safety
25 Mar 2026 //
GLOBENEWSWIRE
Minerva Neurosciences Hosts Virtual KOL Event On Roluperidone
26 Jan 2026 //
GLOBENEWSWIRE
Minerva Neurosciences Appoints Dr. Inderjit Kaul To Board
19 Nov 2025 //
GLOBENEWSWIRE
Minerva Neurosciences Unveils Q3 Financials & Business Update
05 Nov 2025 //
GLOBENEWSWIRE
Minerva Neurosciences Updates Business, Reports Q2 Financial
14 Aug 2025 //
GLOBENEWSWIRE

Market Place
Sourcing Support